Clinical Trials Directory

Trials / Terminated

TerminatedNCT05273151

A Study With Intranasal Kinetic Oscillation Stimulation (KOS) in the Prevention of Chronic Migraine

An Open Pilot Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine on Patients Not Responding to a Preventive Treatment Targeting the CGRP Pathway

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Chordate Medical · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

An open pilot study, non-controlled, single center investigation.

Detailed description

An open pilot study, non-controlled, single center investigation. The study consists of a 4-week screening period, a 6-week treatment period, and a 12 week follow-up period. Subjects who provided written informed consent and are eligible for the study will be asked to complete a daily diary for 4 weeks during the screening period. In the diary the subjects will record headache and migraine days, any changes in their health, and concomitant medications they may be using. The data collected in the diary during this screening period will be used as Baseline for the performance assessments. Subjects who completed the screening period and continue to meet the eligibility criteria after review of diary entries by the investigator will receive treatment. The subjects will receive 6 treatments with the Chordate System S220 at weekly intervals at the site (Day 0 to 35; treatment Visit \[V\] 1 to 6) and continue to maintain a daily diary. After completion of the 6-week study treatment period (V1 to V6), subjects will be treated monthly and followed up for another 12 weeks. The final visit will be performed on Day 125, 12 weeks after the last study treatment. During the 12-week follow-up, the subjects will continue to complete a daily diary.

Conditions

Interventions

TypeNameDescription
DEVICEKOS (Intranasal kinetic oscillation stimulation)Treatment is 10 minutes in each nasal cavity. Totally 2 x 10 minutes per treatment.

Timeline

Start date
2023-12-04
Primary completion
2025-06-03
Completion
2025-06-30
First posted
2022-03-10
Last updated
2025-07-31

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05273151. Inclusion in this directory is not an endorsement.